Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 401

1.

International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin.

Guimarães PO, Lopes RD, Alexander JH, Thomas L, Hellkamp AS, Hijazi Z, Hylek EM, Gersh BJ, Garcia DA, Verheugt FWA, Hanna M, Flaker G, Vinereanu D, Granger CB.

J Thromb Thrombolysis. 2019 Apr 10. doi: 10.1007/s11239-019-01858-1. [Epub ahead of print]

PMID:
30972712
2.

Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil: The BRIDGE Cardiovascular Prevention Cluster Randomized Clinical Trial.

Machline-Carrion MJ, Soares RM, Damiani LP, Campos VB, Sampaio B, Fonseca FH, Izar MC, Amodeo C, Pontes-Neto OM, Santos JY, Gomes SPDC, Saraiva JFK, Ramacciotti E, Barros E Silva PGM, Lopes RD, Brandão da Silva N, Guimarães HP, Piegas L, Stein AT, Berwanger O; BRIDGE Cardiovascular Prevention Investigators.

JAMA Cardiol. 2019 Apr 3. doi: 10.1001/jamacardio.2019.0649. [Epub ahead of print]

PMID:
30942842
3.

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial.

Guimarães PO, Pokorney SD, Lopes RD, Wojdyla DM, Gersh BJ, Giczewska A, Carnicelli A, Lewis BS, Hanna M, Wallentin L, Vinereanu D, Alexander JH, Granger CB.

Clin Cardiol. 2019 Mar 24. doi: 10.1002/clc.23178. [Epub ahead of print]

4.

Atrial fibrillation: what do we know about screening and what do we not know about treatment?

Pokorney SD, Lopes RD.

Heart. 2019 Mar 21. pii: heartjnl-2018-314518. doi: 10.1136/heartjnl-2018-314518. [Epub ahead of print] No abstract available.

PMID:
30898850
5.

Ticagrelor versus Clopidogrel in Patients with STEMI Treated with Fibrinolytic Therapy: TREAT Trial.

Berwanger O, Lopes RD, Moia DDF, Fonseca FA, Jiang L, Goodman SG, Nicholls SJ, Parkhomenko A, Averkov O, Tajer C, Malaga G, Saraiva JFK, Guimaraes HP, de Barros E Silva PGM, Damiani LP, Santos RHN, Paisani DM, Miranda TA, Valeis N, Piegas LS, Granger CB, White HD, Nicolau JC.

J Am Coll Cardiol. 2019 Mar 12. pii: S0735-1097(19)33879-3. doi: 10.1016/j.jacc.2019.03.011. [Epub ahead of print]

PMID:
30898608
6.

Peripheral blood metabolite profiles associated with new onset atrial fibrillation.

Harskamp RE, Granger TM, Clare RM, White KR, Lopes RD, Pieper KS, Granger CB, Newgard CB, Shah SH, Newby LK.

Am Heart J. 2019 May;211:54-59. doi: 10.1016/j.ahj.2019.01.010. Epub 2019 Feb 14. French.

PMID:
30889527
7.

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.

Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O, Bahit MC, Berwanger O, Budaj A, Hijazi Z, Parkhomenko A, Sinnaeve P, Storey RF, Thiele H, Vinereanu D, Granger CB, Alexander JH; AUGUSTUS Investigators.

N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17.

PMID:
30883055
8.

Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018.

Fanaroff AC, Califf RM, Windecker S, Smith SC Jr, Lopes RD.

JAMA. 2019 Mar 19;321(11):1069-1080. doi: 10.1001/jama.2019.1122.

PMID:
30874755
9.

Eating Late Negatively Affects Sleep Pattern and Apnea Severity in Individuals With Sleep Apnea.

Lopes TDVC, Borba ME, Lopes RDVC, Fisberg RM, Lemos Paim S, Vasconcelos Teodoro V, Zalcman Zimberg I, Crispim CA.

J Clin Sleep Med. 2019 Mar 15;15(3):383-392. doi: 10.5664/jcsm.7658.

PMID:
30853037
10.

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.

Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Alexander KP, Senior R, Boden WE, Stone GW, Goodman SG, Lopes RD, Lopez-Sendon J, White HD, Maggioni AP, Shaw LJ, Min JK, Picard MH, Berman DS, Chaitman BR, Mark DB, Spertus JA, Cyr DD, Bhargava B, Ruzyllo W, Wander GS, Chernyavskiy AM, Rosenberg YD, Maron DJ; ISCHEMIA Research Group.

JAMA Cardiol. 2019 Feb 27. doi: 10.1001/jamacardio.2019.0014. [Epub ahead of print]

PMID:
30810700
11.

Zika and Chikungunya Virus and Risk for Venous Thromboembolism.

Ramacciotti E, Agati LB, Aguiar VCR, Wolosker N, Guerra JC, de Almeida RP, Alves JC, Lopes RD, Wakefield TW, Comerota AJ, Walenga J, Fareed J.

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029618821184. doi: 10.1177/1076029618821184.

PMID:
30808213
12.

Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial.

Washam JB, Hohnloser SH, Lopes RD, Wojdyla DM, Vinereanu D, Alexander JH, Gersh BJ, Hanna M, Horowitz J, Hylek EM, Xavier D, Verheugt FWA, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators.

J Thromb Thrombolysis. 2019 Apr;47(3):345-352. doi: 10.1007/s11239-019-01823-y.

PMID:
30790160
13.

Efficacy and Safety of Apixaban versus Warfarin in Patients with Atrial Fibrillation and Extremes in Body Weight: Insights from the ARISTOTLE Trial.

Hohnloser SH, Fudim M, Alexander JH, Wojdyla DM, Ezekowitz JA, Hanna M, Atar D, Hijazi Z, Bahit MC, Al-Khatib SM, Lopez-Sendon JL, Wallentin L, Granger CB, Lopes RD.

Circulation. 2019 Feb 18. doi: 10.1161/CIRCULATIONAHA.118.037955. [Epub ahead of print]

PMID:
30773022
14.

Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.

Wang KL, Lopes RD, Patel MR, Büller HR, Tan DS, Chiang CE, Giugliano RP.

Eur Heart J. 2018 Dec 22. doi: 10.1093/eurheartj/ehy802. [Epub ahead of print]

PMID:
30590440
15.

Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials.

Fanaroff AC, Clare R, Pieper KS, Mahaffey KW, Melloni C, Green JB, Alexander JH, Jones WS, Harrison RW, Mehta RH, Povsic TJ, Moreira HG, Al-Khatib SM, Roe MT, Kong DF, Mathews R, Tricoci P, Holman RR, Wallentin L, Held C, Califf RM, Alexander KP, Lopes RD.

Circulation. 2019 Feb 12;139(7):863-873. doi: 10.1161/CIRCULATIONAHA.118.037202.

PMID:
30586739
16.

Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding.

Van der Wall SJ, Lopes RD, Aisenberg J, Reilly P, van Ryn J, Glund S, Elsaesser A, Klok FA, Pollack CV Jr, Huisman MV.

Circulation. 2019 Feb 5;139(6):748-756. doi: 10.1161/CIRCULATIONAHA.118.036710. Erratum in: Circulation. 2019 Feb 5;139(6):e36.

PMID:
30586692
17.

Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial.

Alexander KP, Brouwer MA, Mulder H, Vinereanu D, Lopes RD, Proietti M, Al-Khatib SM, Hijazi Z, Halvorsen S, Hylek EM, Verheugt FWA, Alexander JH, Wallentin L, Granger CB; ARISTOTLE Investigators.

Am Heart J. 2019 Feb;208:123-131. doi: 10.1016/j.ahj.2018.09.017. Epub 2018 Nov 22.

PMID:
30579505
18.

Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial.

Low Wang CC, Blomster JI, Heizer G, Berger JS, Baumgartner I, Fowkes FGR, Held P, Katona BG, Norgren L, Jones WS, Lopes RD, Olin JW, Rockhold FW, Mahaffey KW, Patel MR, Hiatt WR; EUCLID Trial Executive Committee and Investigators.

J Am Coll Cardiol. 2018 Dec 25;72(25):3274-3284. doi: 10.1016/j.jacc.2018.09.078.

PMID:
30573030
19.

Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial.

Held C, White HD, Stewart RAH, Davies R, Sampson S, Chiswell K, Silverstein A, Lopes RD, Heldestad U, Budaj A, Mahaffey KW, Wallentin L; STABILITY Investigators.

Am Heart J. 2019 Feb;208:65-73. doi: 10.1016/j.ahj.2018.10.010. Epub 2018 Nov 7.

20.

Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes.

Fanaroff AC, Cyr D, Neely ML, Bakal J, White HD, Fox KAA, Armstrong PW, Lopes RD, Ohman EM, Roe MT.

Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e004755. doi: 10.1161/CIRCOUTCOMES.118.004755.

PMID:
30562068

Supplemental Content

Loading ...
Support Center